-
1
-
-
0030114263
-
Effect of molecular weight of chitosan with the same degree of deacetylation on the thermal, mechanical and permeability properties of the prepared membrane
-
Chen R.H., and Hwa H.D. Effect of molecular weight of chitosan with the same degree of deacetylation on the thermal, mechanical and permeability properties of the prepared membrane. Carbohydr. Polym. 29 (1996) 353-358
-
(1996)
Carbohydr. Polym.
, vol.29
, pp. 353-358
-
-
Chen, R.H.1
Hwa, H.D.2
-
3
-
-
33745888169
-
-
Daly, M.M., Keown, R.W., Knorr, D.W., 1989. Chitosan alginate capsules, United States Patent Number 4,808,707.
-
-
-
-
5
-
-
0028381285
-
Hemoglobin encapsulation in chitosan/calcium alginate beads
-
Hugnat M.L., Groboillot A., Neufeld R., Poncelt J., and Dellacherie D.E. Hemoglobin encapsulation in chitosan/calcium alginate beads. J. Appl. Polym. Sci. (1994) 1427-1432
-
(1994)
J. Appl. Polym. Sci.
, pp. 1427-1432
-
-
Hugnat, M.L.1
Groboillot, A.2
Neufeld, R.3
Poncelt, J.4
Dellacherie, D.E.5
-
6
-
-
0035401108
-
Characterization of METHOCEL cellulose ethers by aqueous SEC with multiple detectors
-
Keary C.M. Characterization of METHOCEL cellulose ethers by aqueous SEC with multiple detectors. Carbohydr. Polym. 45 (2001) 293-303
-
(2001)
Carbohydr. Polym.
, vol.45
, pp. 293-303
-
-
Keary, C.M.1
-
7
-
-
33745919611
-
-
Lim, F., 1982 Encapsulation of biological material, United States Patent No. 4,352,883.
-
-
-
-
8
-
-
0037437074
-
Investigations on the drug releasing mechanism from an asymmetric membrane-coated capsule with an in situ formed delivery orifice
-
Lin Y.K., and Ho H.O. Investigations on the drug releasing mechanism from an asymmetric membrane-coated capsule with an in situ formed delivery orifice. J. Control. Release 89 (2003) 57-69
-
(2003)
J. Control. Release
, vol.89
, pp. 57-69
-
-
Lin, Y.K.1
Ho, H.O.2
-
9
-
-
0031375574
-
Chitosan tablets for controlled release of theophylline: Effect of polymer - drug wet or dry blending and anionic-cationic interpolymer complex
-
Mi F.L., Her N.L., Kuan C.Y., Wong T.B., and Shyu S.S. Chitosan tablets for controlled release of theophylline: Effect of polymer - drug wet or dry blending and anionic-cationic interpolymer complex. J. Appl. Polym. Sci. 66 (1997) 2495-2505
-
(1997)
J. Appl. Polym. Sci.
, vol.66
, pp. 2495-2505
-
-
Mi, F.L.1
Her, N.L.2
Kuan, C.Y.3
Wong, T.B.4
Shyu, S.S.5
-
11
-
-
33745907910
-
-
Rha, C., Rodriguez-Sanchez, D., 1988. Process for encapsulation and encapsulated active material system. United State Patent No. 4,744,933.
-
-
-
-
12
-
-
0026670086
-
Immobilization of yeast cells with cross-linked chitosan beads
-
Shinonaga M.A., Kawamura Y., and Yamane T. Immobilization of yeast cells with cross-linked chitosan beads. J. Ferment. Bioeng. 74 (1992) 90-94
-
(1992)
J. Ferment. Bioeng.
, vol.74
, pp. 90-94
-
-
Shinonaga, M.A.1
Kawamura, Y.2
Yamane, T.3
-
13
-
-
1842843556
-
The influence of multivalent phosphate structure on the properties of ionically cross-linked chitosan films for controlled drug release
-
Shu X.Z., and Zhu K.J. The influence of multivalent phosphate structure on the properties of ionically cross-linked chitosan films for controlled drug release. Eur. J. Pharm. Biopharm. 54 (2002) 235-243
-
(2002)
Eur. J. Pharm. Biopharm.
, vol.54
, pp. 235-243
-
-
Shu, X.Z.1
Zhu, K.J.2
-
14
-
-
33745926603
-
-
Suzuki, T., Hashiudo, K., Matsumoto, T., Higashide, T., 1994. Large intestinal dissociative hard capsules. United State Patent No. 5,283,064.
-
-
-
-
15
-
-
0033582731
-
Colon-specific delivery of R68070, a new thromboxane synthase inhibitor, using chitosan capsules: therapeutic effects against 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats
-
Tozaki H., Fujita T., and Odoriba T. Colon-specific delivery of R68070, a new thromboxane synthase inhibitor, using chitosan capsules: therapeutic effects against 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats. Life Sci. 64 (1999) 1155-1162
-
(1999)
Life Sci.
, vol.64
, pp. 1155-1162
-
-
Tozaki, H.1
Fujita, T.2
Odoriba, T.3
-
16
-
-
0037133084
-
Formulation aspects in the development of osmotically controlled oral drug delivery systems
-
Verma R.K., Krishna D., and Garg M.S. Formulation aspects in the development of osmotically controlled oral drug delivery systems. J. Control. Release 79 (2002) 7-27
-
(2002)
J. Control. Release
, vol.79
, pp. 7-27
-
-
Verma, R.K.1
Krishna, D.2
Garg, M.S.3
-
17
-
-
19344372357
-
Asymmetric membrane capsules for delivery of poorly water soluble drugs by osmotic effects
-
Wang C.Y., Ho H.O., Lin L.H., Lin Y.K., and Sheu M.T. Asymmetric membrane capsules for delivery of poorly water soluble drugs by osmotic effects. Int. J. Pharm. 297 (2005) 89-97
-
(2005)
Int. J. Pharm.
, vol.297
, pp. 89-97
-
-
Wang, C.Y.1
Ho, H.O.2
Lin, L.H.3
Lin, Y.K.4
Sheu, M.T.5
|